Navigation Links
Biomarker May Predict Response to Cancer Therapy
Date:4/13/2008

Dutch researchers identify cell type that is potential target for these agents

SUNDAY, April 13 (HealthDay News) -- A biomarker that may help doctors monitor the effectiveness of common treatments for kidney cancer and non-small cell lung cancer has been identified by researchers in the Netherlands.

The researchers found that CD34bright/CD133neg candidate circulating Endothelial Progenitor Cells (ccEPCs) are a potential biomarker during treatment with sunitinib (Sutent) or bevacizumab (Avastin).

"Our work provides novel data on a potential biomarker for the monitoring of anti-angiogenic drug activity in cancer patients, as well as identifies a cell type that is a potential target for these agents," Laura Vroling, a researcher in the department of medical oncology at VU University Medical Center in Amsterdam, said in a prepared statement.

Vroling and her colleagues noted that bevacizumab and sunitinib, which target the vascular endothelial growth factor (VEGF), have proven effective against a number of cancers, but doctors aren't able to determine which patients might derive the most benefit from these drugs.

"Therefore, it is of great importance to identify and validate biomarkers for early response or duration of response," Vroling said.

She and her team studied 23 patients with renal cell cancer and 19 patients with non-small cell lung cancer.

"In our study, for the first time, the behavior of two CD34bright cell populations, (CD45neg) candidate cEPcs and (CD45dim) HPCs (hematopoietic progenitor cells), were monitored and showed a different response of both cell populations during sunitinib or bevacizumab therapy. The role of ccEPCs in human tumor angiogenesis and their potential in prediction of treatment outcome of anti-VEGF therapy needs to be addressed in future, larger clinical cohorts," Vroling said.

The study findings were to be presented Sunday at the annual meeting of the American Association for Cancer Research, in San Diego.

More information

The National Academies Press has more about cancer biomarkers.



-- Robert Preidt



SOURCE: American Association for Cancer Research, news release, April 13, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Biomarkers may reduce need for biopsies
2. Scientists: New technique identifies molecular biomarkers for disease
3. Biomarker May Signal HIV Progression
4. Expansion of monocyte subset could serve as a biomarker for HIV progressions
5. Biomarkers and Innovation Push Global Cancer Diagnostics Market Toward $8 Billion
6. Biomarkers for Mood May Alter Psychiatric Treatments
7. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
8. Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer
9. New developments in biomarkers for epithelial ovarian cancer
10. Biomarkers for Alzheimers disease can be trusted in clinical trials
11. JDRF and Lilly partner to fund research to identify beta cell biomarkers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... (BIAA) is collaborating with a New England student to educate the public on ... acclaim in 2016 for launching the first-ever National Concussion Awareness Day. , Brooke ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... recently launched community enrichment program. Partnering once again with Boys & Girls Clubs ... to help find the area’s very own American Idol. With all proceeds benefitting ...
(Date:8/16/2017)... ... , ... LabRoots , the leading provider of educational and interactive virtual ... announce Andrew Ly as the winner of the LabRoots Summer Textbook scholarship, awarding him ... who is in his third year at the University of California, Los Angeles majoring ...
(Date:8/16/2017)... ... 2017 , ... Melbourne’s reign as the world’s most liveable city has been ... Liveability Index. , The Index surveys 140 of the world’s cities and Melbourne has ... consistently come in the top three of the index. So what is it that ...
(Date:8/16/2017)... ... August 16, 2017 , ... Connexion Point, a technology-enabled healthcare services company ... fourth consecutive year. With 197% revenue growth over the past three years, ... growing companies. , Previous honors include ranking 86th on the Inc. 500 ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... WILMINGTON, N.C. , Aug. 15, 2017 ... Wilmington, NC , today announced that the company ... at the University of North Carolina at Chapel Hill ... AccuKit-HIV is designed to characterize and quantify HIV reservoir ... and after pharmacological intervention. The HIV Cure Center is ...
(Date:8/10/2017)... 2017  Physical Rehabilitation Network (PRN), acquired the long-standing outpatient ... Colorado . The reputable clinic will continue to be ... with his staff of four clinicians. Lipkin received his doctorate ... over 10 years of experience with a strong background in ... marks the 10th PRN clinic in and around the ...
(Date:8/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... Board of Directors has approved the payment of a quarterly ... The cash dividend of ... 27, 2017 to stockholders of record as of the close ... are subject to approval of the Board of Directors and ...
Breaking Medicine Technology: